| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sera Prognostics, Inc. (SERA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 2 sells. SERA is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 738.3K | $1.35M | - | |
| CFO | 264.5K | $483.9K | - | |
| Other | 164.0K | $300.0K | - | |
| Other | 163.9K | $300.0K | - | |
| Other | 145.8K | $266.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 | Boniface John J.56 | Chief Scientific Officer | Sell | 2,725 | $3.68 | $10,028.00 | -2.8% | -64.3% | +9.9% | |
| Mar 14, 2022 | Boniface John J.56 | Chief Scientific Officer | Sell | 2,725 | $3.94 | $10,736.50 | -2.7% | -70.0% | +4.2% |